Knoll Capital Management as of Dec. 31, 2016
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 17 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Corbus Pharmaceuticals Hldgs | 38.0 | $22M | 2.6M | 8.45 | |
| Abeona Therapeutics | 20.1 | $11M | 2.4M | 4.85 | |
| Vascular Biogenics | 7.3 | $4.2M | 861k | 4.85 | |
| Anavex Life Sciences (AVXL) | 5.0 | $2.9M | 724k | 3.96 | |
| Ritter Pharmaceuticals | 4.5 | $2.6M | 952k | 2.71 | |
| Alcobra | 4.4 | $2.5M | 1.2M | 2.10 | |
| Ampio Pharmaceuticals | 4.4 | $2.5M | 2.7M | 0.91 | |
| Volitionrx (VNRX) | 3.7 | $2.1M | 462k | 4.53 | |
| Advaxis | 2.8 | $1.6M | 225k | 7.16 | |
| Synthetic Biologics | 2.7 | $1.5M | 2.0M | 0.76 | |
| Keryx Biopharmaceuticals | 2.1 | $1.2M | 200k | 5.86 | |
| Newlink Genetics Corporation | 1.7 | $963k | 94k | 10.29 | |
| Aldeyra Therapeutics (ALDX) | 1.3 | $727k | 136k | 5.35 | |
| Advaxis | 0.8 | $446k | 113k | 3.96 | |
| Ohr Pharmaceutical | 0.5 | $306k | 204k | 1.50 | |
| Bio Blast Pharma | 0.4 | $214k | 206k | 1.04 | |
| Caladrius Biosciences Ord | 0.3 | $157k | 56k | 2.82 |
